The results revealed that individuals whose serum GAL-1 levels > 41.83 ng/mL were significantly associated with the presence of glioma than those whose GAL-1 levels below 41.83 ng/mL (OR: 6.05, p < 0.01). Here, LGALS1 is linked to glioma.